KoVidone® K25
KoVidone® K25 are an essential ingredient to formulating highly effective pharmaceutical products. The polymers are produced in a state of the art manufacturing facility operating under full cGMP compliance. In addition, all physical handling and packaging of powders is conducted in class-D clean rooms with specific attention placed on reducing the risk of any potential particulate/foreign matter contamination. KoVidone® K series products possess excellent binding, film-forming, dispersing and thickening properties and are widely used.
Properties
- Physical Form
- Powder
- Solid
- Pharma and Nutraceuticals Functions
- Binder
- Coating System
- Dispersant
- Film Former
- Solubilizer
- Stabilizer
- Suspending Agent
- Thickener
Product families
Applications
- Ophthalmic
- Oral
- Parenteral
- Topical
- Transdermal
Product Families
- Binders & Disintegrants
- Emulsifiers & Stabilizers
- Formulation & Processing Aids
- Pharmaceutical Coatings
- Solvents & Solubilizers
Other characteristics
- Brand
- KoVidone
- Synonyms
1-Vinyl-2-pyrrolidinone polymer, 1-Vinyl-2-pyrrolidone homopolymer, 1-Vinyl-2-pyrrolidone polymer, 1-Vinylpyrrolidin-2-one homopolymer, n-Octyl mercaptan-N-vinylpyrrolidone copolymer, N-Vinyl-2-pyrolidone homopolymer, N-Vinyl-2-pyrrolidinone homopolymer, N-Vinyl-2-pyrrolidone homopolymer, N-Vinyl-2-pyrrolidone polymer, N-Vinylbutyrolactam polymer, N-Vinylpyrrolidinone homopolymer, N-Vinylpyrrolidinone polymer, N-Vinylpyrrolidone homopolymer, N-Vinylpyrrolidone polymer, Poly(1-vinyl-2-pyrrolidinone), Poly(1-vinyl-2-pyrrolidone), Poly(1-vinylpyrrolidinone), Poly(N-vinyl-2-pyrrolidinone), Poly(N-vinyl-2-pyrrolidone), Poly(N-vinyl-γ-butyrolactam), Poly(N-vinylbutyrolactam), Poly(N-vinylpyrrolidinone), Poly(N-vinylpyrrolidone), Poly(vinylpyrrolidinone), Poly(vinylpyrrolidone), Polyvinyl polypyrrolidone, Polyvinylpyrrolidone, Povidone, Vinylpyrrolidinone polymer, Vinylpyrrolidone homopolymer, Vinylpyrrolidone polymer
- Functions
Binder, Coating System, Dispersant, Film Former, Solubilizer, Stabilizer, Suspending Agent, Thickener, Viscosity Modifier
- Dosage Form
Capsules, Dispersions, Eye Drops, Granules, Suspension, Tablets; Capsules; Dispersions; Eye Drops; Granules; Suspension; Tablets
- Labeling Claims
- Non-Irritant, Non-Toxic, Pyrogen-free
- Non-Irritant
- Non-Toxic
- Pyrogen-free
- Certifications & Compliance
British Pharmacopeia (BP), European Pharmacopeia (Ph. Eur.), Indian Pharmacopeia, Japan Pharmacopeia (JP), Korean Pharmacopeia, United States Pharmacopeia (USP), cGMP
- Grade
- Pharma Grade
- Markets
- Healthcare & Pharma
- Technology
- Pharmaceuticals & Nutraceuticals
- HIGHLIGHTS
Nontoxic.; Non-irritant.; Hygroscopic.; Freely soluble in water, alcohol and most other organic solvents.; Very slightly soluble in acetone.; Excellent solubility.; Film-forming.; Chemical stability.; Physiologically inert.; Complexation and binding property.
- Manufacturing Technology
- Direct Compression
- Dry Granulation
- Wet Granulation
- Certifications and Compliance
- British Pharmacopeia (BP)
- European Pharmacopeia (Ph. Eur.)
- Indian Pharmacopeia
- Japan Pharmacopeia (JP)
- Korean Pharmacopeia
- United States Pharmacopeia (USP)
- cGMP
- Known For
- Binder
- suitable for wet and dry granulation and direct compression in tableting, improves particle compressibility and can be added to powder blends in dry or granulated forms by the addition of water, alcohol or hydro-alcoholic solutions.
- Solubilizer
- suitable for oral and parenteral formulations, enhancing the solubility of poorly soluble drugs in solid dispersion forms
- Coating agent or binder
- coating of active pharmaceutical ingredients on a support structure.
- Suspending, stabilizing or viscosity-modifying agent: suitable for topical and oral suspension and solution applications. The solubility of poorly soluble drugs may be enhanced by combining with KoVidone.
Technical data
Table 1 of 1
2 rows| Characteristic | Value |
|---|---|
| K value | 22.5 - 27.0 |
| Viscosity-Average Molecular Weight | 30000 - 40000 |
